Single center series: Melanoma (2002)

Record number: 
287
Adverse Occurrence type: 
MPHO Type: 
Estimated frequency: 
Most recent risk assessment for melanoma (Council of Europe, 2022): Due to the very aggressive behaviour of this tumour, it is considered an unacceptable risk for organ donation. Malignant melanoma in the donor history: Due to the lack of exhaustive data, transplanting organs from donors with treated malignant melanoma must still be considered to be associated with a high transmission risk. If precise donor data about staging, therapy, follow-up and recurrence-free survival are available, and evaluation by the dermato-oncologist concludes there is a low probability of recurrence and metastasis, organ donation might be considered for selected recipients.
Time to detection: 
12 months
Alerting signals, symptoms, evidence of occurrence: 
Diagnosed in the recipient 12 months after transplant. Patient Death.
Demonstration of imputability or root cause: 
Found in the donor 4 years before Tx.
Groups audience: 
Suggest new keywords: 
Single center series
Kidney transplant
Suggest references: 
AAA
Expert comments for publication: 
Series from Odense University Hospital, Odense, Denmark. This is the only transmission of cancer in the series.